Sunday, 31 August 2008

Beijing's Health Department Distributes No-Cost Condoms, HIV/AIDS Pamphlets To Olympic Hotels

div























Latest News For Sexual Health / STDs
Cellular Ringtone Launched In India To Promote Condom Use, Curb Spread Of HIV
21 Aug 2008

BioVex Announces Regulatory Clearance To Commence A Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate For Genital Herpes
21 Aug 2008

Most New Jersey Adults Support Instruction On Birth Control In High Schools, Survey Finds
20 Aug 2008

View more than news...

Latest Videos for Sexual Health
Adherence Matters



As with other HIV medications, antiretrovirals are designed to be interpreted on a particular docket, whether it's once, twice, or trey times per day. Side effects commode make these regimens hard to wedge to -- and many patients don't. Unfortunately, the consequences of slipping from your...


View more videos...




Most Popular Categories



cancer �
cardiovascular �
dermatology �
hiv �
nutrition �

diabetes �
obesity �
pediatrics �
psychology �
neurology �
alcohol �

urology �
breast cancer �
women's health �
infectious diseases �
respiratory �
sexual health �

gastrointestinal �
pain �
pregnancy �
bones �
medical devices �
medicare �

depression �
prostate �
smoking �
alzheimer's �
allergy �
sleep �

biology �
genetics �
eye health �
sports medicine �
hypertension �
abortion �

health insurance �
autism �
stem cell research �
adhd �
liver disease �
multiple sclerosis �

arthritis �
pharma industry �
seniors �
dentistry �
it �
nursing �

blood �
fertility �

















More info

Monday, 11 August 2008

Brangie: Let's Cut Out the Baby Fat

Brad and Angie got $14 mil for pics of the twins. We got way more for our money's worth -- at $14 a pop for baby pics of TMZ users. Here's the deal: The babies are just as cute, and some even gave us the finger ... they cognize us so well!
Baby  photos: Click  to view pics!





More info

Wednesday, 6 August 2008

Long Acting Neuraminidase Inhibitor (LANI) Phase II Completed - Phase III Scheduled -Naturally Acquired Influenza A Or B

� Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) proclaimed that its second generation, influenza treatment, CS-8958, has successfully completed its initial Phase II clinical rating, showing favorable outcomes against all metric endpoints. The initial Phase III visitation is scheduled to start later this year. CS-8958 is a long performing neuraminidase inhibitor (LANI), and is co-owned with Daiichi-Sankyo Company Limited (TYO:4758)(PINK:DSKYF).




The Phase II clinical tryout was intentional to test the safety and efficacy of CS-8958 in several hundred adult patients world Health Organization had confirmed, naturally acquired influenza A or B using fever and symptom resolution endpoints after a single inhaled dose. The study was conducted in accordance with guidance from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). In the double-blinded trial, inhaled CS-8958 administered once only was statistically indisting! uishable from 75mg of oseltamivir administered twice daily for! 5 conse cutive days. In earlier presymptomatic tests, CS-8958 has likewise shown